Enterprise Trust & Investment’s iShares Biotechnology ETF IBB Stock Holding History

Enterprise Trust & Investment’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$69K	Hold	590	–	–	0.03%	112
2022 Q1	$77K	Hold	590	–	–	0.03%	103
2021 Q4	$90K	Hold	590	–	–	0.03%	105
2021 Q3	$95K	Hold	590	–	–	0.04%	99
2021 Q2	$97K	Hold	590	–	–	0.04%	101
2021 Q1	$89K	Hold	590	–	–	0.04%	101
2020 Q4	$93K	Hold	590	–	–	0.04%	98
2020 Q3	$80K	Hold	590	–	–	0.04%	95
2020 Q2	$81K	Buy	+590	New	+$75.2K	0.05%	94

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Enterprise Trust & Investment's IBB Position: Q2 2022 in Review

Enterprise Trust & Investment held its iShares Biotechnology ETF (IBB) position steady in Q2 2022 at 590 shares worth $69K. The position accounts for 0.03% of the portfolio, ranked #112.

Enterprise Trust & Investment first reported a position in IBB in Q2 2020 and has held it in 9 quarters since. The position peaked at $97K in Q2 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Enterprise Trust & Investment held 590 shares of iShares Biotechnology ETF worth $69K as of Q2 2022.
Enterprise Trust & Investment left its iShares Biotechnology ETF share count unchanged in Q2 2022.
iShares Biotechnology ETF made up 0.03% of Enterprise Trust & Investment's portfolio in Q2 2022, its #112 holding.
Enterprise Trust & Investment first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 9 quarters since.
Enterprise Trust & Investment's iShares Biotechnology ETF position peaked at $97K in Q2 2021.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.